An efficient drug development process and rapid review and approval are the goals of every pharmaceutical sponsor, but numerous factors make this goal difficult and sometimes impossible to achieve. Although some of these factors are beyond the control of the sponsor, many delays in the regulatory process can be avoided by conceiving a robust regulatory strategy early in the development process. When a regulatory strategy document is prepared prior to development planning and updated throughout the development process, it provides the project team with a valuable reference resource and guideline, enabling them to make informed decisions in line with FDA requirements. This will ultimately reduce avoidable delays in the development, review, and approval processes and allow for the marketing of important new drugs.
We have demonstrated with many of our clients that a modern, state-of-the-art integrated drug development approach, using quantitative methods to inform, guide, and supplant traditional development methods, dramatically improves efficiency and reduces costs. Our team of experts work as an integrated part of your team, asking and answering questions, leveraging the most innovative modeling and simulation technologies and providing deep scientific and regulatory acumen to impact the Return of Investment of the clients R&D investment.
Copyright © 2021 PharmaPro Consulting Inc. - All Rights Reserved.